[1]
Amtul Mussawar Sami, “Intravitreal Bevacizumab (Avastin) for Primary Treatment of Diffuse Diabetic Macular Oedema”, Esculapio - JSIMS, vol. 5, no. 2, pp. 5–8, Aug. 2023.